已收盤 09-19 16:00:00 美东时间
-0.390
-1.38%
JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris.
09-07 01:46
J.P. Morgan reevaluated its coverage of the North American specialty pharma space on Friday, downgrading the generic drugmaker Organon (NYSE:OGN) and upgrading its smaller peer Amneal Pharmaceuticals ...
09-06 20:39
DUBLIN, Aug. 27, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and ...
08-27 20:30
培瑞克(Perrigo Company plc)宣布任命David Ball博士为执行副总裁兼首席品牌和数字官。他从拜耳消费者保健部门加入培瑞克,在拜耳他担任北...
08-20 16:40
Perrigo (NYSE:PRGO) has voluntarily recalled 16,500 cans of its store brand Premium Infant Formula with Iron Milk-Based Powder that were shipped to H-E-B Grocery Company and CVS (CVS). The healthcare ...
08-09 23:07
When a single insider purchases stock, it is typically not a major deal. Howeve...
08-06 02:12
Fiscal Year 2024 Outlook: Company updates its fiscal 2024 organic net sales growth outlook versus the prior year to -3% to -1%, from +1% to +3%, and total net sales
08-02 18:39
Perrigo Company PLC: Sees Fiscal 2024 Organic Net Sales Growth Outlook Versus P...
08-02 18:36
Perrigo Company PLC: Expected Lower Distribution in U.S. Store Brand in Second ...
08-02 18:36